Sanofi

🇫🇷France

Country: 🇫🇷France

Ownership: Public

Employees: 87.9K

Market Cap: $141.3B

Website: http://www.sanofi.com

Introduction: Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.

Clinical Trials

Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™

Phase 3

Completed

Conditions: Diphtheria
Tetanus
Haemophilus Infection
Pertussis
Polio

First Posted Date: 2008-10-15

Last Posted Date: 2012-02-01

Lead Sponsor: Sanofi

Target Recruit Count: 1167

Registration Number: NCT00772928

Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity

Phase 1

Terminated

Conditions: Clostridium Difficile Diarrhea
Clostridium Difficile Infection

Interventions: Biological: Vaccine diluent buffer
Biological: Clostridium difficile toxoid vaccine (50 μg)
Biological: Clostridium difficile toxoid vaccine (100 μg)

First Posted Date: 2008-10-15

Last Posted Date: 2012-05-21

Lead Sponsor: Sanofi

Target Recruit Count: 36

Registration Number: NCT00772954

Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma

Phase 4

Completed

Conditions: Head and Neck Neoplasms

Interventions: Drug: docetaxel and cisplatin

First Posted Date: 2008-10-15

Last Posted Date: 2009-12-07

Lead Sponsor: Sanofi

Target Recruit Count: 57

Registration Number: NCT00772681

Locations: 🇹🇷
Sanofi-Aventis Administrative Office, Istanbul, Turkey

Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer

Phase 2

Completed

Conditions: Ovarian Neoplasms

First Posted Date: 2008-10-15

Last Posted Date: 2009-10-29

Lead Sponsor: Sanofi

Target Recruit Count: 37

Registration Number: NCT00772863

Locations: 🇹🇷
Sanofi aventis administrative office, Istanbul, Turkey

Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis

Phase 2

Completed

Conditions: Optic Nerve
Multiple Sclerosis
Neuritis

Interventions: Drug: Nerispirdine
Drug: Placebo

First Posted Date: 2008-10-15

Last Posted Date: 2016-02-26

Lead Sponsor: Sanofi

Target Recruit Count: 31

Registration Number: NCT00772525

Locations: 🇺🇸
Sanofi-Aventis Administrave Office, Bridgewater, New Jersey, United States

Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe Hypercholesterolemia

Phase 3

Terminated

Conditions: Hypercholesterolemia

Interventions: Drug: AVE5530
Drug: Placebo

First Posted Date: 2008-10-06

Last Posted Date: 2016-05-16

Lead Sponsor: Sanofi

Target Recruit Count: 643

Registration Number: NCT00766688

Locations: 🇺🇦
Sanofi-Aventis Administrative Office, Kiev, Ukraine
🇦🇺
sanofi-aventis Australia & New Zealand administrative office, Macquarie Park, New South Wales, Australia

GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone

Phase 3

Completed

Conditions: Diabetes Mellitus Type 2

Interventions: Drug: Lixisenatide (AVE0010)
Drug: Placebo
Device: Pen auto-injector
Drug: Pioglitazone
Drug: Metformin

First Posted Date: 2008-10-01

Last Posted Date: 2016-11-28

Lead Sponsor: Sanofi

Target Recruit Count: 484

Registration Number: NCT00763815

Locations: 🇺🇸
Sanofi-Aventis Investigational Site Number 840708, Kalamazoo, Michigan, United States
🇺🇸
Sanofi-Aventis Investigational Site Number 840792, Columbia, South Carolina, United States
🇺🇸
Sanofi-Aventis Investigational Site Number 840855, Mobile, Alabama, United States

and more 147 locations